临床严重度分期系统与舌下神经刺激治疗阻塞性睡眠呼吸暂停的疗效反应
这项单中心回顾性队列研究纳入119例接受舌下神经刺激器(HGNS)植入的阻塞性睡眠呼吸暂停(OSA)患者,70%达到改良Sher应答标准。颈围、BMI、AHI评分和合并症负担与应答相关,据此构建的四分类临床严重度分期系统具有中等区分能力(C统计量0.68,95%CI 0.57-0.78)。
要点
- 颈围、BMI、AHI和合并症负担是HGNS应答的4个易获取相关因素。
- 小颈围、BMI<30且AHI≤30者应答率最高(11例中91%应答)。
- 大颈围、BMI≥30、AHI≥30且伴合并症者应答率最低(16例中38%应答)。
核心结论
- 颈围、BMI、AHI评分和合并症负担与HGNS应答相关,据此构建的四分类临床严重度分期系统或有助于识别最可能受益于植入的患者。
- 该分期系统具有中等区分能力(C统计量0.68,95%CI 0.57-0.78),但需在独立队列中验证。
研究设计与样本
- 共194例接受HGNS植入,最终纳入119例进行分析;中位年龄63岁(范围33-79岁),女性36例(30%)。
主要发现
- 119例中83例(70%)为应答者(改良Sher标准:AHI降低>50%且术后AHI<15)。
- 颈围小(女性≤14英寸或男性≤16英寸)、BMI<30且AHI≤30者应答率最高(11例中91%)。
- 颈围大(女性>14英寸或男性>16英寸)、BMI≥30、AHI≥30且伴合并症者应答率最低(16例中38%)。
关键数值与推荐
- 应答定义为改良Sher标准:AHI降低>50%且术后AHI<15。
- 分期系统基于颈围、BMI、AHI评分和合并症负担构建四分类。
- 分期系统区分能力C统计量0.68(95%CI 0.57-0.78)。
临床怎么用
- 可利用颈围、BMI、AHI和合并症负担等易获取指标评估OSA患者HGNS植入的预期应答概率。
- 对具备小颈围、低BMI、低AHI且无合并症特征的患者,HGNS应答可能性较高。
局限性
- 单中心回顾性设计,结果需在独立队列中验证。
- 仅纳入完成术后睡眠监测的119例,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: While hypoglossal nerve stimulators (HGNS) have been shown to be associated with reduced apnea-hypopnea index (AHI) scores in many continuous positive airway pressure-intolerant patients with obstructive sleep apnea (OSA), it is not effective for all patients, and it is unclear who would benefit most. OBJECTIVE: To explore baseline factors associated with response to HGNS and create a prognostic stratification system. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included patients with OSA who underwent implant with an HGNS from April 2019 to October 2023 at a single tertiary care center and received a postimplant sleep study. During that time, 194 patients underwent HGNS implant. Data were analyzed from February 2024 to April 2024. INTERVENTION OR EXPOSURE: HGNS implant and sleep study. MAIN OUTCOMES AND MEASURES: Response according to the modified Sher criteria (>50% reduction in AHI score and AHI <15 postimplant). RESULTS: Among the 119 patients included, the median (range) age was 63 (33-79) years, and 36 (30%) were female. Of the 119 included, 83 (70%) were responders. Neck size, body mass index (BMI; calculated as weight in kilograms divided by height in meters squared), AHI score, and comorbidity burden were associated with response and used to create a 4-category clinical severity staging system. Patients with small necks (≤14 inches for women or ≤16 inches for men), a BMI of less than 30, and an AHI score of 30 or less had the highest response rate (11 [91%]). Patients with large necks (>14 inches for women or >16 inches for men), a BMI of 30 or greater, an AHI score of 30 or greater, and comorbidities had the lowest response rate (16 [38%]). The staging system had moderate discriminative power, with a C statistic of 0.68 (95% CI, 0.57-0.78). CONCLUSIONS AND RELEVANCE: The results of this cohort study suggest that neck size, BMI, AHI score, and comorbidity burden are 4 clinically relevant and easily obtainable values that are associated with response to HGNS. While this staging system may help physicians identify patients who are most likely to benefit from implant, these results need to be validated in a separate cohort.
引用
- Ji J, Wang HZ, Jackson RS, et al. Clinical Severity Staging System and Response to Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 41642599. doi:10.1001/jamaoto.2025.4851
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。